Catalyst Wire Dossier Catalyst Wire Dossier

HWH486

· Hubei Biological Medicine Industrial Technology Institute Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HWH486, covering 2024-03-07 to 2024-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria [Phase 2]

See pricing